Next-Gen Bioprotection: CreatiPhage Reinvents Infection Control for Emergency Response
Advanced Bacteriophage Solutions for Safer, Healthier Crisis Environments
CREATIPHAGE BIOTECHNOLOGY CO., LTD. is a pioneering life sciences company focused on developing bacteriophage-based technologies to combat bacterial contamination and infection—especially in challenging environments such as disaster zones, field hospitals, and temporary shelters. Headquartered in Shanghai, CreatiPhage integrates biotechnology research, clinical science, and practical applications to offer natural, targeted microbial control without relying on conventional antibiotics or harsh chemicals.
Because natural disasters often result in compromised sanitation and increased risk of infection, CreatiPhage’s innovative solutions play a crucial role in improving health safety during emergencies. Moreover, their products are environmentally friendly, residue-free, and highly specific—making them both safe and sustainable for wide-scale deployment in disaster-prone areas like Indonesia.
Key Products and Technologies
CreatiPhage specializes in phage-based disinfection and pathogen control systems designed to neutralize dangerous bacteria in high-risk environments. Their core technologies include:
-
Phage Disinfectant Sprays – Formulated with targeted bacteriophages to eliminate pathogens like E. coli, Salmonella, and Listeria on surfaces in healthcare and food preparation areas.
-
Wound Care Phage Solutions – Topical treatments using bacteriophages to prevent or treat bacterial infections in cuts, burns, and trauma wounds—ideal for use in mobile clinics and disaster relief camps.
-
Phage Aerosol Sanitization Units – Engineered to disperse phage mist in enclosed spaces, reducing airborne and surface-level contamination in shelters or emergency transport vehicles.
-
Water Purification Additives – Phage-based agents that help reduce microbial contamination in emergency water supplies.
In addition, all products are rigorously tested for safety, stability, and efficacy, and meet global biosafety and regulatory standards.
Why It Matters in Indonesia
Indonesia’s frequent natural disasters often lead to poor sanitation, overcrowded shelters, and the rapid spread of bacterial diseases. Consequently, fast-acting and targeted antimicrobial solutions are essential. CreatiPhage’s bacteriophage-based systems offer a novel, effective approach to infection control without contributing to antibiotic resistance.
Visit CREATIPHAGE BIOTECHNOLOGY CO., LTD. at EDRR Indonesia and explore how biotechnology can protect public health in the most critical moments—naturally and precisely.
Meet CREATIPHAGE BIOTECHNOLOGY CO., LTD. (Hall A, booth H18) at EDRR Indonesia
CREATIPHAGE BIOTECHNOLOGY CO., LTD. invites importers, public sector leaders, and manufacturers to explore collaborations at EDRR Indonesia. Together, let’s build a safer, more resilient Indonesia.
Visit EDDR Indonesia 2025 to discover their live solutions, explore partnership opportunities, and learn how they support faster, cleaner disaster recovery nationwide.
